Antifungal efficacy of Au@ carbon dots nanoconjugates against opportunistic fungal pathogen, Candida albicans

被引:34
|
作者
Priyadarshini, Eepsita [1 ]
Rawat, Kamla [2 ,3 ]
Prasad, Tulika [2 ,4 ]
Bohidar, H. B. [1 ,2 ]
机构
[1] Jawaharlal Nehru Univ, Sch Phys Sci, New Delhi, India
[2] Jawaharlal Nehru Univ, Special Ctr Nano Sci, New Delhi, India
[3] Inter Univ Accelerator Ctr, New Delhi, India
[4] Jawaharlal Nehru Univ, Adv Instrument Res Facil, New Delhi, India
关键词
Gold-carbon dot nanoconjugates; Candida albicans; Fluorescence; Cytotoxicity; MULTIDRUG-RESISTANCE; EPIDEMIOLOGY; PLATFORM;
D O I
10.1016/j.colsurfb.2018.01.006
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
In the current study, we have investigated the toxicological effect of a novel hydrophilic nanoconjugate gold@carbon dot (Au@CD) and carbon dots (CDs) on the opportunistic fungal pathogen, Candida albicans. A homogenous experimental analysis was conducted for determining the toxicity of Au@CDs nanoconjugates of five different sizes ranging from 22 +/- 2 to 35 +/- 3 nm prepared using the carbon dots of mean hydrodynamic radius 12 1 nm. The smallest size of nanoconjugate was synthesized using 0.3 mg ml(-1) HAtiCl(4) precursor. Our study for the first time, conclusively establishes the size-dependent toxicity effect of these characterized nanoconjugates against the abovementioned fungal pathogen. The MIC80 value of smaller sized Au@CDs nanoconjugates, S1-S3 samples were 250, 500 and 500 mu g ml(-1), respectively, while nanoconjugates of R-h diameter greater than 30 nm (S4 and S5 samples) did not show any toxicity. The results thus demonstrate that alteration in composition (carbon vs Au@CDs) exhibits a profound effect on the susceptibility of Candida albicans cells. While a size-dependent toxicity was observed for the nanoconjugates, CDs were found to be quite toxic owing to their small size which facilitated their entry into the cells and challenged the biocompatibility of carbon allotropes. (C) 2018 Elsevier B.V. All rights reserved.
引用
收藏
页码:355 / 361
页数:7
相关论文
共 50 条
  • [1] Messenger RNA transport in the opportunistic fungal pathogen Candida albicans
    McBride, Anne E.
    [J]. CURRENT GENETICS, 2017, 63 (06) : 989 - 995
  • [2] Messenger RNA transport in the opportunistic fungal pathogen Candida albicans
    Anne E. McBride
    [J]. Current Genetics, 2017, 63 : 989 - 995
  • [3] Biocompatible carbon quantum dots as versatile imaging nanotrackers of fungal pathogen - Candida albicans
    Rais, Anam
    Sharma, Shubham
    Mishra, Prashant
    Khan, Luqman Ahmad
    Prasad, Tulika
    [J]. NANOMEDICINE, 2024, 19 (08) : 671 - 688
  • [4] The role of manganese in morphogenesis and pathogenesis of the opportunistic fungal pathogen Candida albicans
    Wildeman, Asia S. S.
    Patel, Naisargi K. K.
    Cormack, Brendan p P.
    Culotta, Valeria C. C.
    [J]. PLOS PATHOGENS, 2023, 19 (06)
  • [5] IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans
    Conti, Heather R.
    Gaffen, Sarah L.
    [J]. JOURNAL OF IMMUNOLOGY, 2015, 195 (03): : 780 - 788
  • [6] pH-Dependant Antifungal Activity of Valproic Acid against the Human Fungal Pathogen Candida albicans
    Chaillot, Julien
    Tebbji, Faiza
    Garcia, Carlos
    Wurtele, Hugo
    Pelletier, Rene
    Sellam, Adnane
    [J]. FRONTIERS IN MICROBIOLOGY, 2017, 8
  • [7] Human gut bifidobacteria inhibit the growth of the opportunistic fungal pathogen Candida albicans
    Ricci, Liviana
    Mackie, Joanna
    Donachie, Gillian E.
    Chapuis, Ambre
    Mezerova, Kristyna
    Lenardon, Megan D.
    Brown, Alistair J. P.
    Duncan, Sylvia H.
    Walker, Alan W.
    [J]. FEMS MICROBIOLOGY ECOLOGY, 2022, 98 (10)
  • [8] Rac1 Dynamics in the Human Opportunistic Fungal Pathogen Candida albicans
    Vauchelles, Romain
    Stalder, Daniele
    Botton, Thomas
    Arkowitz, Robert A.
    Bassilana, Martine
    [J]. PLOS ONE, 2010, 5 (10):
  • [9] HYDROPHOBIC SURFACE PROTEIN MASKING BY THE OPPORTUNISTIC FUNGAL PATHOGEN CANDIDA-ALBICANS
    HAZEN, KC
    HAZEN, BW
    [J]. INFECTION AND IMMUNITY, 1992, 60 (04) : 1499 - 1508
  • [10] Repurposing FDA approved drugs against the human fungal pathogen, Candida albicans
    Kim, Kevin
    Zilbermintz, Leeor
    Martchenko, Mikhail
    [J]. ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2015, 14